We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Retinal/Chorioretinal Disorders

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Invited Commentary  | 
Drilling Deeper for Treatment Choices in Diabetic Macular Edema
Emily Y. Chew, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
JAMA Ophthalmology
Original Investigation  | 
Clinical Validation of a Smartphone-Based Adapter for Optic Disc Imaging in Kenya
Andrew Bastawrous, MBChB, BSc(Hons), FHEA, MRCOphth; Mario Ettore Giardini, PhD; Nigel M. Bolster, MEng; et al.
Editorial  | 
Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy
Timothy W. Olsen, MD